William A. Gahl

William A. Gahl

Auto-generated profile, based on publicly available information

William A. Gahl

Undiagnosed Diseases Program, National Institutes of Health, Bethesda, MD, USA; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SSSkand Shekhar
Skand Shekhar
JIJorge Irizarry-Caro
Jorge Irizarry-Caro
NSNinet Sinaii
Ninet Sinaii
WGWilliam A. Gahl
William A. Gahl
JEJuvianee Ibrahim Estrada-Veras
Juvianee Ibrahim Estrada-Veras
FHFady Hannah-Shmouni
Fady Hannah-Shmouni
Purpose: We examined abnormal pituitary imaging (API) and associated endocrine dysfunction in subjects with ECD. Methods: A cross-sectional descriptive examination of a natural history cohort study diagnosed with ECD was conducted at a clinical research center. Subjects underwent baseline endocrine tests of anterior and posterior pituitary function and dedicated pituitary gland MRI scans. We determined the frequency of various pituitary imaging abnormalities in ECD and assessed its relationships with age, sex, body mass index (BMI), BRAF V600E status, high sensitivity C-reactive protein (hsCRP), erythrocyte sedimentation rate (ESR), pituitary hormone deficits and number, diabetes insipidus (DI), and panhypopituitarism. Results: Our cohort included 61 subjects with ECD [age (SD): 54.3 (10.9) y, 46 males/15 females]. API was present in 47.5% (29/61) of ECD subjects. Loss of the posterior pituitary bright spot (36.1%) followed by thickened pituitary stalk (24.6%), abnormal enhancement (18.0%), and pituitary atrophy (14.8%) were the most common abnormalities. DI and panhypopituitarism were more frequent in subjects with API without differences in age, sex distribution, hsCRP, ESR, and BRAF V600E status compared to normal pituitary imaging. Conclusions: We noted a high burden of API and endocrinopathies in ECD. API was highly associated with the presence of panhypopituitarism and DI. Therefore, a thorough assessment of hypothalamic–pituitary integrity should be considered in subjects with ECD.

24 November 2023 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
DBDaniel Benavides
Daniel Benavides
AEAnusha Ebrahim
Anusha Ebrahim
JRJuan C. Ravell
Juan C. Ravell
MLMichael Lenardo
Michael Lenardo
WGWilliam A. Gahl
William A. Gahl
CTCamilo Toro
Camilo Toro